YANG Xue-ning, ZHAO Ning. Gefitinib Versus Placebo in Completely Resected Non?Small Cell Lung Cancer: Results of the NCIC CTG BR19 Study[J]. Journal of Evidence-Based Medicine, 2015, 15(1): 29-33. DOI: 10.3969/j.issn.1671-5144.2015.01.010
|
Citation:
|
YANG Xue-ning, ZHAO Ning. Gefitinib Versus Placebo in Completely Resected Non?Small Cell Lung Cancer: Results of the NCIC CTG BR19 Study[J]. Journal of Evidence-Based Medicine, 2015, 15(1): 29-33. DOI: 10.3969/j.issn.1671-5144.2015.01.010
|
YANG Xue-ning, ZHAO Ning. Gefitinib Versus Placebo in Completely Resected Non?Small Cell Lung Cancer: Results of the NCIC CTG BR19 Study[J]. Journal of Evidence-Based Medicine, 2015, 15(1): 29-33. DOI: 10.3969/j.issn.1671-5144.2015.01.010
|
Citation:
|
YANG Xue-ning, ZHAO Ning. Gefitinib Versus Placebo in Completely Resected Non?Small Cell Lung Cancer: Results of the NCIC CTG BR19 Study[J]. Journal of Evidence-Based Medicine, 2015, 15(1): 29-33. DOI: 10.3969/j.issn.1671-5144.2015.01.010
|
DownLoad: